Related Experiment Video
Updated: May 10, 2026
10:10
Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents
Published on: February 15, 2022
A decrease of the rabbit's physiologic IOP after the application of specific amino acids and double combination of
1Department of Ophthalmology, Comenius University, Bratislava, Slovakia. olahz@stonline.sk
Bratislavske Lekarske Listy
|July 5, 2013
Summary
Amino acids like L-arginine and L-taurine, when combined with antiglaucoma medications, may form a new substance that effectively lowers intraocular pressure (IOP). This "bio-antiglaucomatic" shows enhanced IOP reduction in rabbits compared to medications alone.
Area of Science:
- Ophthalmology
- Pharmacology
- Biochemistry
Background:
- Glaucoma management often involves combination antiglaucoma medications to lower intraocular pressure (IOP).
- Investigating novel therapeutic strategies to enhance IOP reduction is crucial for glaucoma treatment.
- Amino acids play vital roles in biological processes and may influence drug efficacy.
Purpose of the Study:
- To compare the IOP-lowering effects of amino acid mixtures with dual antiglaucoma drug combinations in rabbits.
- To explore the potential synergistic or novel effects of combining specific amino acids with antiglaucoma agents.
Main Methods:
- Experimental study involving five female New Zealand White rabbits.
- Instillation of 10% L-arginine hydrochloride or 10% L-taurine hydrochloride in combination with antiglaucoma drugs.
- Measurement of intraocular pressure (IOP) changes over 24 hours.
- Assessment of pupillary diameter changes.
Main Results:
- Instillation of 10% L-arginine HCl with 0.5% Timolol/0.005% Xalatan resulted in a mean 24-hour IOP decrease of -2.9 torr.
- Instillation of 10% L-arginine HCl with 2% Trusopt/0.005% Xalatan resulted in a mean 24-hour IOP decrease of -4.2 torr.
- Instillation of 10% L-taurine HCl with 0.5% Timolol/0.005% Xalatan showed an average 24-hour IOP decrease of -2.8 torr.
- The fixed combination COSOPT showed a mean IOP decrease of -1.8 torr.
- No changes in pupillary diameter were observed.
Conclusions:
- The combination of L-arginine or L-taurine with antiglaucoma medications appears to form a new substance with enhanced IOP-lowering effects.
- "Bio-antiglaucomatic" formation suggests improved penetration and efficacy compared to antiglaucoma drugs alone.
- This interaction may offer a novel therapeutic approach for regulating IOP in glaucoma management.
Related Concept Videos
01:27Open Angle Glaucoma: Treatment
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
01:25Glaucoma: Overview
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
01:28Angle Closure Glaucoma: Treatment
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
01:23Ophthalmic Drug Delivery Systems
Ophthalmic drug delivery faces major limitations due to poor absorption across the corneal membrane. This process is primarily driven by diffusion and is influenced by two main factors: the physicochemical properties of the drug and tear drainage. Most ophthalmic drugs, such as pilocarpine, epinephrine, atropine, and local anesthetics, are weak bases. They are typically formulated at an acidic pH to enhance chemical stability. However, this leads to high ionization, reducing their ability to...